Organovo Holdings Inc.
ONVO Real Time Price USDRecent trades of ONVO by members of U.S. Congress
Politician | Type | Traded |
---|---|---|
William L. Owens House / D | Purchase $1,001 - $15,000 | Nov. 06, 2014 |
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by ONVO's directors and management
Government lobbying spending instances
-
$10,000 Oct 17, 2023 Issue: None
-
$30,000 Jul 18, 2023 Issue: Health Issues
-
$30,000 Jan 19, 2023 Issue: Health Issues
-
$30,000 Oct 12, 2022 Issue: Health Issues
-
$30,000 Jul 18, 2022 Issue: Health Issues
-
$30,000 Apr 13, 2022 Issue: Health Issues
-
$20,000 Jan 13, 2022 Issue: Health Issues
-
$20,000 Apr 14, 2016 Issue: Health Issues
-
$20,000 Jan 13, 2016 Issue: Health Issues
-
$30,000 Oct 13, 2015 Issue: Health Issues
-
$10,000 Jul 14, 2015 Issue: Health Issues
-
$10,000 Apr 17, 2015 Issue: Health Issues
-
$20,000 Jan 20, 2015 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Methods for tissue fabrication Jul. 16, 2024
-
Patent Title: Use of engineered renal tissues in assays May. 14, 2024
-
Patent Title: Engineered renal tissues, arrays thereof, and methods of making the same Jan. 09, 2024
-
Patent Title: Bioprinted hair follicles and uses thereof Dec. 26, 2023
-
Patent Title: Farnesoid x receptor agonists and uses thereof Oct. 03, 2023
-
Patent Title: Engineered intestinal tissue and uses thereof May. 23, 2023
-
Patent Title: Bioprinter for the fabrication of tissue Feb. 14, 2023
-
Patent Title: Methods for the fabrication of tissue via printing Feb. 14, 2023
-
Patent Title: Engineered three-dimensional skin tissues, arrays thereof, and methods of making the same Dec. 20, 2022
-
Patent Title: Bioprinter for the fabrication of tissue Aug. 16, 2022
-
Patent Title: Use of engineered renal tissues in assays Mar. 08, 2022
-
Patent Title: Engineered liver tissues, arrays thereof, and methods of making the same Sep. 21, 2021
-
Patent Title: Devices, systems, and methods for the fabrication of tissue Apr. 06, 2021
-
Patent Title: Engineered renal tissues, arrays thereof, and methods of making the same Mar. 30, 2021
-
Patent Title: Engineered liver tissues, arrays thereof, and methods of making the same Sep. 03, 2019
-
Patent Title: Devices, systems, and methods for the fabrication of tissue utilizing uv cross-linking Jan. 08, 2019
-
Patent Title: Engineered renal tissues, arrays thereof, and methods of making the same Oct. 09, 2018
-
Patent Title: Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model May. 29, 2018
-
Patent Title: Method of printing a three-dimensional structure Jan. 02, 2018
-
Patent Title: Devices, systems, and methods for the fabrication of tissue utilizing uv cross-linking Nov. 22, 2016
-
Patent Title: Engineered renal tissues, arrays thereof, and methods of making the same Nov. 01, 2016
-
Patent Title: Engineered liver tissues, arrays thereof, and methods of making the same Sep. 13, 2016
-
Patent Title: Automated devices, systems, and methods for the fabrication of tissue Apr. 19, 2016
-
Patent Title: Devices, systems, and methods for the fabrication of tissue Jan. 05, 2016
-
Patent Title: Engineered liver tissues, arrays thereof, and methods of making the same Dec. 29, 2015
-
Patent Title: Devices, systems, and methods for the fabrication of tissue Oct. 06, 2015
-
Patent Title: Devices, systems, and methods for the fabrication of tissue Jan. 13, 2015
Federal grants, loans, and purchases
No Government Contracts for this ticker
Government Contracts DashboardEstimated quarterly amount awarded from public contracts
Number of mentions of ONVO in WallStreetBets Daily Discussion
Recent insights relating to ONVO
Recent picks made for ONVO stock on CNBC
ETFs with the largest estimated holdings in ONVO
Shareholder
|
Shares Held
|
---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ONVO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.